Retatrutide reduces knee pain and body weight in osteoarthritis patients

by rss feed | Nov 9, 2026 | News Feeds

For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. Read Original...

Searching for medicine in Europe? Not every Google result is what it seems

by rss feed | Nov 9, 2026 | News Feeds

A study examining 9,000 Google search results across 30 European countries found that 36.3% of links to online medicine sellers led to illegal vendors, rising to nearly 77% for controlled substances. Countries that permitted legitimate online medicine sales generally...

GLP-1 weight-loss drugs may change what you crave, not just how much you eat

by rss feed | Nov 9, 2026 | News Feeds

A prospective observational pilot study of 38 adults without diabetes found that three months of semaglutide or tirzepatide treatment was associated with an average weight loss of 7.2 kg, reduced food cravings, increased satiety, and improved self-reported hunger...

Weekly reads: Huntington’s treatment hope, AI & the idea of a science paper, misuse of 3-parent IVF (MRT), death of young stem cell biologist

by rss feed | Nov 8, 2026 | Deaths & Tributes, News Feeds

As long as I’ve been doing The Niche, I’ve been looking out for a possible truly promising new Huntington’s treatment. My focus has mainly been on the cell and gene therapy space. Now, we have groundbreaking news of FDA acceptance of a BLA for an...

Common overactive bladder drugs may not increase dementia risk

by rss feed | Nov 7, 2026 | News Feeds

New research, published November 6th in JAMA Network Open, finds anticholinergic medications, commonly prescribe for overactive bladder (OAB), may not increase dementia risk after all compared to beta-3 agonists, the newer drug class that has been presumed to be safer...